Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edouard Laforgue"'
Autor:
Benoit Schreck, Marylène Guerlais, Edouard Laforgue, Célia Bichon, Marie Grall-Bronnec, Caroline Victorri-Vigneau
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Background“Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with t
Externí odkaz:
https://doaj.org/article/d5035eb0f32e4e49a043b7193f0df01c
Autor:
Audrey Verholleman, Caroline Victorri-Vigneau, Edouard Laforgue, Pascal Derkinderen, Celine Verstuyft, Marie Grall-Bronnec
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8, p 3002 (2020)
Hypersexuality is a well-known adverse side effect of dopamine replacement therapy (DRT), and anti-craving drugs could be an effective therapeutic option. Our aim was to update the knowledge on this issue, particularly on the influence of an Opioid R
Externí odkaz:
https://doaj.org/article/42fb501c97b9444ea1f20ce07c2174ac
Autor:
Benoit Schreck, Marie Grall-Bronnec, Caroline Victorri-Vigneau, Marylène Guerlais, Edouard Laforgue
Publikováno v:
European Addiction Research. 27:161-178
Background: Slamming has been developing since 2011 as a new international phenomenon, mostly among men who have sex with men (MSM). It consists of intravenous drug injection before or during planned sexual activity to sustain, enhance, disinhibit, o
Autor:
Caroline Victorri-Vigneau, Morgane Guillou-Landreat, Antoine Dany, Juliette Leboucher, Gaëlle Challet-Bouju, Marie Grall-Bronnec, Edouard Laforgue, Jean-Benoit Hardouin
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩
International Journal of Environmental Research and Public Health, Vol 18, Iss 1425, p 1425 (2021)
International Journal of Environmental Research and Public Health, MDPI, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩
International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩
International Journal of Environmental Research and Public Health, Vol 18, Iss 1425, p 1425 (2021)
International Journal of Environmental Research and Public Health, MDPI, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩
(1) Background: Opioid use disorder (OUD) is a complex condition that can require long-term treatment. Pharmacological therapy for OUD involves treatment with opioid agonists (OMT) tailored to individual profiles. The aim of our study in daily clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65bef5b0406e15649fa0911d83d32a02
https://doi.org/10.3390/ijerph18041425
https://doi.org/10.3390/ijerph18041425
Autor:
Samuel Bulteau, Marie Guitteny, Anne Sauvaget, Nelly Doligez, Caroline Victorri-Vigneau, Jean-Marie Vanelle, Edouard Laforgue
Publikováno v:
Annales Médico-psychologiques, revue psychiatrique. 174:70-76
Resume L’interet des antidepresseurs dans le traitement curatif de la depression bipolaire est tres controverse. Cependant ils representent la premiere classe medicamenteuse prescrite dans cette indication. La persistance de cet usage important peu
Publikováno v:
Annales Médico-psychologiques, revue psychiatrique. 174:60-63
Resume L’episode depressif majeur est une pathologie dont la frequence et la gravite ont un impact socioeconomique important. Les antidepresseurs valides dans cette indication, bases sur l’hypothese tri-mono-aminergique, ont une efficience global
Autor:
Pierre Valrivière, Elisabeth Auffray-Calvier, Annabelle Bonnin-Rivalland, Anne Pichot, Véronique Sébille, Edouard Laforgue, Samuel Bulteau, Anne Sauvaget, Guillemette Fayet, Thibault Deschamps, Véronique Thomas-Ollivier, June Fortin, Jean-Marie Vanelle, Yann Péréon
Publikováno v:
Trials
Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩
Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩
Background The treatment of depression remains a challenge since at least 40% of patients do not respond to initial antidepressant therapy and 20% present chronic symptoms (more than 2 years despite standard treatment administered correctly). Repetit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77dd4974363df889f4ea03001ac412e4
https://hal.archives-ouvertes.fr/hal-03158125
https://hal.archives-ouvertes.fr/hal-03158125
Autor:
Juliette Leboucher, Marie Grall-Bronnec, Céline Verstuyft, Edouard Laforgue, Gaëlle Challet-Bouju G, Régis Bouquié, Jean-Benoit Hardouin, Caroline Victorri-Vigneau
Publikováno v:
Therapies. 73:563
Introduction La grande variabilite interindividuelle de la pharmacocinetique et des concentrations plasmatiques de methadone est fortement liee a une variabilite de l’activite des cytochromes P450 (CYP). Des etudes recentes ont souligne l’importa